Ranbaxy has filed a complaint against the U.S. FDA in federal court and has also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided, the company said in the press release.
Shares of the company were seen trading lower by 4% at Rs 603 on BSE at 3.00 pm IST. Stock touched an intra-day low of Rs 596.
Earlier this month, the company had received communication from the US FDA wherein FDA has determined that Ranbaxy's ANDAs of concern did not have any data integrity issues. Ranbaxy was disappointed with this and was actively evaluating all available options to preserve its rights.
Also, Ranbaxy will be moved out of NSE's CNX Nifty Junior index. The changes are due to merger with Sun Pharmaceuticals Industries Ltd.
GoodReturns.in
Notifications
Settings
Clear Notifications
No New Notifications
Notifications
Use the toggle to switch on notifications
Block for 8 hours
Block for 12 hours
Block for 24 hours
Don't block
To start receiving timely alerts, as shown below click on the Green “lock” icon next to the address bar
Click it and Unblock the Notifications
Close X
Close X
To Start receiving timely alerts please follow the below steps:
Click on the Menu icon of the browser, it opens up a list of options.
Click on the “Options ”, it opens up the settings page,
Here click on the “Privacy & Security” options listed on the left hand side of the page.
Scroll down the page to the “Permission” section .
Here click on the “Settings” tab of the Notification option.
A pop up will open with all listed sites, select the option “ALLOW“, for the respective site under the status head to allow the notification.
Once the changes is done, click on the “Save Changes” option to save the changes.
Click it and Unblock the Notifications
Sign in with Google